Albert Ferrer Olivera
Founder at Invivo Capital Partners SGEIC SA
Profile
Albert Ferrer Olivera is the founder of Invivo Capital Partners SGEIC SA, which was founded in 2019.
He is currently the Director at GlyCardial Diagnostics SL, Pulmobiotics SL, Gyala Therapeutics SL, and Telum Therapeutics SL.
In the past, he held positions as the Director of Investment at Riva y Garcia Gestión SGIIC SA, Director at Scytl Secure Electronic Voting SA, and Director at WeCare-U Comunicación SL.
From 2007 to 2017, he served as an Investment Manager at Riva y García Gestión SGIIC SA. Mr. Ferrer Olivera received a graduate degree from Hautes Etudes Commerciales in 1998 and has an undergraduate degree and an MBA from Escuela Superior de Administración y Dirección de Empresas.
Albert Ferrer Olivera active positions
Companies | Position | Start |
---|---|---|
Invivo Capital Partners SGEIC SA
Invivo Capital Partners SGEIC SA Investment ManagersFinance Invivo Capital Partners SGEIC SA (Invivo Capital Partners) is a venture capital firm founded in 2019 by Albert Ferrer and Luis Pareras. The firm is headquartered in Barcelona, Spain. | Founder | 2019-02-28 |
Pulmobiotics SL
Pulmobiotics SL BiotechnologyHealth Technology Pulmobiotics SL operates as a spin off company. The firm uses its technology to discover and develop novel treatments and vaccines for respiratory diseases. The company was founded by Maria Lluch and Lluis Serrano and is headquartered in Barcelona, Spain. | Director/Board Member | - |
GlyCardial Diagnostics SL
GlyCardial Diagnostics SL Miscellaneous Commercial ServicesCommercial Services GlyCardial Diagnostics SL has developed a biomarker called iSCOR that can detect cardiac ischemia through a blood test. The company is based in Barcelona, Spain. Early detection of ischemia can prevent myocardial damage. The Spanish company was founded in 2017 by Rafols Judit Cubedo, Lina Badimon Maestro, Capmany Teresa Padro, and Gemma Vilahur. Rafols Judit Cubedo has been the CEO since 2017. | Director/Board Member | - |
Telum Therapeutics SL
Telum Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Telum Therapeutics SL is a Spanish biotechnology company that specializes in drug discovery and the use of Innovative Phage Lytic Proteins as antibiotics. The company is based in Noáin, Spain. The company has specific programs to treat serious multidrug-resistant Gram-negative infections caused by Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa. Telum Therapeutics leverages the power of nature through the understanding of biological controls exerted by bacteriophages to balance bacterial ecosystems. The CEO of the company is Roberto Díez-Martínez. | Director/Board Member | - |
Gyala Therapeutics SL
Gyala Therapeutics SL BiotechnologyHealth Technology Gyala Therapeutics SL develops CAR-T therapies for treating hematological malignancies. The company is based in Barcelona, Spain. Claudio Santos has been the CEO of the Spanish company since 2020. | Director/Board Member | - |
Former positions of Albert Ferrer Olivera
Companies | Position | End |
---|---|---|
Riva y García Gestión SGIIC SA /New/
Riva y García Gestión SGIIC SA /New/ Investment ManagersFinance Riva y García Gestión SGIIC SA (Riva y Garcia Private Equity) is a private equity and venture capital subsidiary of Grupo Financiero Riva y García SL /New/ founded in 2000 by Borja García-Nieto Portabella. It is headquartered in Barcelona, Spain. | Private Equity Analyst | 2006-12-31 |
Riva y Garcia Gestión SGIIC SA
Riva y Garcia Gestión SGIIC SA Investment ManagersFinance Riva y Garcia Gestión SGIIC SA (Riva y Garcia) is the Barcelona-based fund management subsidiary of Riva y Garcia Proyectos, itself a subsidiary of Grupo Financiero Riva y García in Spain. Established in 1990, the firm manages funds and SICAVs for individual and institutional investors. | Chief Investment Officer | - |
WeCare-U Comunicación SL
WeCare-U Comunicación SL Publishing: Books/MagazinesConsumer Services WeCare-U Comunicación SL is a holding company engages in the publication and distribution of journals, periodicals, digital editions on news, and developments in the health sector. It also provides corporate communications and public relations services to clients in the healthcare industry. Its also provides services such as consulting, content design, printing, television program production, event organization, and workshop facilitation. The company was founded on September 7, 1999 and is headquartered in Madrid, Spain. | Director/Board Member | - |
Scytl Secure Electronic Voting SA
Scytl Secure Electronic Voting SA Information Technology ServicesTechnology Services Scytl Secure Electronic Voting SA provides electronic and online voting, election management and election modernization solutions. It offers election training, online voter registration, candidate management, electronic ballot delivery and results consolidation. The company was founded by Jorba Andreu Riera and Carles Rovira in 2001 and is headquartered in Barcelona, Spain. | Director/Board Member | - |
Training of Albert Ferrer Olivera
Escuela Superior de Administración y Dirección de Empresas | Undergraduate Degree |
Hautes Etudes Commerciales | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 9 |
---|---|
Riva y García Gestión SGIIC SA /New/
Riva y García Gestión SGIIC SA /New/ Investment ManagersFinance Riva y García Gestión SGIIC SA (Riva y Garcia Private Equity) is a private equity and venture capital subsidiary of Grupo Financiero Riva y García SL /New/ founded in 2000 by Borja García-Nieto Portabella. It is headquartered in Barcelona, Spain. | Finance |
Scytl Secure Electronic Voting SA
Scytl Secure Electronic Voting SA Information Technology ServicesTechnology Services Scytl Secure Electronic Voting SA provides electronic and online voting, election management and election modernization solutions. It offers election training, online voter registration, candidate management, electronic ballot delivery and results consolidation. The company was founded by Jorba Andreu Riera and Carles Rovira in 2001 and is headquartered in Barcelona, Spain. | Technology Services |
WeCare-U Comunicación SL
WeCare-U Comunicación SL Publishing: Books/MagazinesConsumer Services WeCare-U Comunicación SL is a holding company engages in the publication and distribution of journals, periodicals, digital editions on news, and developments in the health sector. It also provides corporate communications and public relations services to clients in the healthcare industry. Its also provides services such as consulting, content design, printing, television program production, event organization, and workshop facilitation. The company was founded on September 7, 1999 and is headquartered in Madrid, Spain. | Consumer Services |
Riva y Garcia Gestión SGIIC SA
Riva y Garcia Gestión SGIIC SA Investment ManagersFinance Riva y Garcia Gestión SGIIC SA (Riva y Garcia) is the Barcelona-based fund management subsidiary of Riva y Garcia Proyectos, itself a subsidiary of Grupo Financiero Riva y García in Spain. Established in 1990, the firm manages funds and SICAVs for individual and institutional investors. | Finance |
Invivo Capital Partners SGEIC SA
Invivo Capital Partners SGEIC SA Investment ManagersFinance Invivo Capital Partners SGEIC SA (Invivo Capital Partners) is a venture capital firm founded in 2019 by Albert Ferrer and Luis Pareras. The firm is headquartered in Barcelona, Spain. | Finance |
Pulmobiotics SL
Pulmobiotics SL BiotechnologyHealth Technology Pulmobiotics SL operates as a spin off company. The firm uses its technology to discover and develop novel treatments and vaccines for respiratory diseases. The company was founded by Maria Lluch and Lluis Serrano and is headquartered in Barcelona, Spain. | Health Technology |
GlyCardial Diagnostics SL
GlyCardial Diagnostics SL Miscellaneous Commercial ServicesCommercial Services GlyCardial Diagnostics SL has developed a biomarker called iSCOR that can detect cardiac ischemia through a blood test. The company is based in Barcelona, Spain. Early detection of ischemia can prevent myocardial damage. The Spanish company was founded in 2017 by Rafols Judit Cubedo, Lina Badimon Maestro, Capmany Teresa Padro, and Gemma Vilahur. Rafols Judit Cubedo has been the CEO since 2017. | Commercial Services |
Telum Therapeutics SL
Telum Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Telum Therapeutics SL is a Spanish biotechnology company that specializes in drug discovery and the use of Innovative Phage Lytic Proteins as antibiotics. The company is based in Noáin, Spain. The company has specific programs to treat serious multidrug-resistant Gram-negative infections caused by Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa. Telum Therapeutics leverages the power of nature through the understanding of biological controls exerted by bacteriophages to balance bacterial ecosystems. The CEO of the company is Roberto Díez-Martínez. | Commercial Services |
Gyala Therapeutics SL
Gyala Therapeutics SL BiotechnologyHealth Technology Gyala Therapeutics SL develops CAR-T therapies for treating hematological malignancies. The company is based in Barcelona, Spain. Claudio Santos has been the CEO of the Spanish company since 2020. | Health Technology |
- Stock Market
- Insiders
- Albert Ferrer Olivera